May 29, 2026
1 min read

Ocrelizumab Effective In Slowing Progressive MS, Trial Shows MedNews

FRIDAY, May 29, 2026 An already-approved MS drug can significantly slow progression in people with primary progressive multiple sclerosis (PPMS), according to a

Leave a Reply

Your email address will not be published.

Previous Story

Long COVID Might Be Twice As Common As Previously Thought MedNews

Next Story

Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding MedNews

Previous Story

Long COVID Might Be Twice As Common As Previously Thought MedNews

Next Story

Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding MedNews

Latest from Blog

Go toTop